MitoChem Therapeutics, Inc. — Form D/A
MitoChem Therapeutics, Inc. of CHARLESTON, SC, a company, filed a Form D amendment with the SEC on 2020-12-18. The offering totals $300K, of which $236K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-12-18
- Form: D/A
- Accession: 0001836268-20-000005
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $300K
- Amount sold: $236K
- Remaining: $64K
- Investors: 7
- Date of first sale: 2020-12-02
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-383566
Issuer
- Name: MitoChem Therapeutics, Inc.
- CIK: 0001836268
- Entity type: Corporation
- Jurisdiction: NORTH CAROLINA
- Address: 624 MEETING STREET, CHARLESTON, SC, 29403
- Phone: 520-204-5552
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Gyda Caren Beeson | Director | Charleston, SC |
| Baerbel G Rohrer | Director | Charleston, SC |
| Rick G Schnellman | Director | Charleston, SC |
| Michael Voevodsky | Director | Tucson, AZ |
| Michael Voevodsky | Executive Officer | Tucson, AZ |
Other filings by this issuer (1)
More